Filing Details
- Accession Number:
- 0001437749-22-028031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-23 16:16:08
- Reporting Period:
- 2022-11-21
- Accepted Time:
- 2022-11-23 16:16:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738781 | Audrey Kunin | C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608 | Chief Product Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-21 | 5,960 | $2.10 | 0 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
- This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Billionaire Hedge Funds
